title: [Percutaneous treatment of aortic stenosis].
abstract: Degenerative aortic stenosis is the most frequent valvular disease in developed countries. The reference treatment is surgical valve replacement but one third of the patients are not eligible for surgery. Alternative options have been recently proposed using transcatheter valve implantation (transfemoral or trans-apical approaches) in this subset of patients. Two models of valve (balloon expandable or self-expandable) have demonstrated their efficacy and have been implanted to date in over 4000 patients worldwide. These techniques are promising but several issues remain such as the selection of patients, and the safety and durability of the devices currently used.
authors.affiliation: Service de cardiologie, hôpital Charles-Nicolle, CHU de Rouen, 1, rue de Germont 76000 Rouen, France. matthieu.godin@chu-rouen.fr
authors.forename: M
authors.initials: M
authors.lastname: Godin
authors.forename: C
authors.initials: C
authors.lastname: Tron
authors.forename: H
authors.initials: H
authors.lastname: Eltchaninoff
authors.forename: B
authors.initials: B
authors.lastname: Baala
authors.forename: A
authors.initials: A
authors.lastname: Cribier
mesh_terms: D001024:Aortic Valve Stenosis / Q000601:surgery*; D001807:Blood Vessel Prosthesis; D019917:Blood Vessel Prosthesis Implantation / Q000379:methods / Q000639:trends; D005544:Forecasting; D006801:Humans; D018579:Patient Selection; D011474:Prosthesis Design; D014656:Vascular Surgical Procedures / Q000379:methods